Silverarc Capital Management LLC a acheté des actions de Scholar Rock Holding Co. Silverarc Capital Management LLC purchased shares of Scholar Rock Holding Co.

Silverarc Capital Management LLC a acheté 9 711 actions de Scholar Rock Holding Co. (NASDAQ : SRRK) pour un investissement de 69 000 $ au troisième trimestre. Silverarc Capital Management LLC purchased 9,711 shares of Scholar Rock Holding Co. (NASDAQ:SRRK) for a $69,000 investment in Q3. D'autres investisseurs, comme la Banque Royale du Canada et la Banque Amalgamée, ont également augmenté leurs participations dans SRRK. Other investors, such as Royal Bank of Canada and Amalgamated Bank, also increased their stakes in SRRK. Silverarc détient des participations dans diverses sociétés de biotechnologie, notamment Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics et Viridian Therapeutics. Silverarc has holdings in various biotech companies, including Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics, and Viridian Therapeutics.